Vincent Vultaggio

Insider Reports History

Entity
Individual
Location
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY
Signature
/s/ Andrea Paul, attorney-in-fact for Vincent Vultaggio
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vincent Vultaggio:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. PAO and Interim PFO Common Stock 190K $325K $1.71 Feb 3, 2025 Direct
Zentalis Pharmaceuticals, Inc. PAO and Interim PFO Stock Option (Right to Buy) 35.6K Feb 3, 2025 Direct

Insider Reports Filed by Vincent Vultaggio

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZNTL Zentalis Pharmaceuticals, Inc. Feb 3, 2025 3 -$4.48K 4 Feb 5, 2025 PAO and Interim PFO
ZNTL Zentalis Pharmaceuticals, Inc. Oct 4, 2024 1 -$5.1K 4 Oct 4, 2024 Principal Accounting Officer
ZNTL Zentalis Pharmaceuticals, Inc. Apr 5, 2024 0 $0 3 Apr 11, 2024 Principal Accounting Officer